Hemophilia Treatment and Research

TopicLeading institutions, researchers & key papers

This cluster of papers focuses on the management and treatment of hemophilia, including prophylaxis, inhibitors, gene therapy, and the impact on joint health. It covers a wide range of topics such as recombinant factor VIII, factor IX, and the safety and efficacy of various treatment strategies.

Works

IDs:OpenAlex

How has Hemophilia Treatment and Research's publication output changed over time?

ScholarIQpublication output · 2004–2023

Output grew100% over the shown period — from 1 works in 2004 to 2 in 2023.

2004200620072008200920102015201820192023

What are the most-cited papers on Hemophilia Treatment and Research?

ScholarIQmost cited works

Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia

Marilyn J. Manco‐Johnson, Thomas C. Abshire, Amy D. Shapiro, Brenda Riske, Michele R. Hacker, Ray F. Kilcoyne, J. David Ingram, M L Manco-Johnson, Sharon Funk, Linda Jacobson, Leonard A. Valentino, W. Keith Hoots, George R. Buchanan, Donna DiMichele, Michael Recht, Deborah Brown, Cindy Leissinger, Shirley Bleak, Alan R. Cohen, Prasad Mathew, Alison Matsunaga, Desiree Medeiros, Diane J. Nugent, Gregory A. Thomas, Alexis A. Thompson, Kevin McRedmond, J. Michael Soucie, Harlan Austin, Bruce L. Evatt

New England Journal of Medicine. 20071,939 CitationsOPEN ACCESS

Safety of Recombinant Activated Factor VII in Randomized Clinical Trials

Marcel Levi, Jerrold H. Levy, Henning Friis Andersen, David Truloff

New England Journal of Medicine. 2010678 CitationsOPEN ACCESS

Nonviral Transfer of the Gene Encoding Coagulation Factor VIII in Patients with Severe Hemophilia A

David A. Roth, Nicholas E. Tawa, Joanne O’Brien, Douglas A. Treco, Richard F. Selden

New England Journal of Medicine. 2001366 CitationsOPEN ACCESS

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B

Steven W. Pipe, Frank W.G. Leebeek, Michael Recht, Nigel S. Key, Giancarlo Castaman, Wolfgang Miesbach, Susan Lattimore, Kathelijne Peerlinck, Paul van der Valk, Michiel Coppens, Peter Kampmann, Karina Meijer, Niamh O’Connell, John Pasi, Daniel P. Hart, Rashid Kazmi, Jan Astermark, Cédric Hermans, Robert Klamroth, Richard S. Lemons, Nathan Visweshwar, Annette von Drygalski, Guy Young, Shelley E. Crary, Miguel A. Escobar, Esteban Gomez, Rebecca Kruse‐Jarres, Doris Quon, Emily Symington, Michael Wang, Allison P. Wheeler, Robert Gut, Ying P. Liu, Ricardo E. Dolmetsch, David L. Cooper, Yanyan Li, Brahm Goldstein, Paul E. Monahan

New England Journal of Medicine. 2023350 CitationsOPEN ACCESS

Results of the CONTROL Trial: Efficacy and Safety of Recombinant Activated Factor VII in the Management of Refractory Traumatic Hemorrhage

Carl J. Hauser, Kenneth D Boffard, Richard P. Dutton, Gordon R. Bernard, Martin A. Croce, John B. Holcomb, Ari Leppäniemi, Michael Parr, Jean‐Louis Vincent, Bartholomew J. Tortella, Jeannett Dimsits, Bertil Bouillon

S2312674. 2010348 Citations